Tamara Potlog | Photosensitizer’s for Photodynamic Therapy | Best Researcher Award

Posted on by ScienceFather

Ms. Tamara Potlog | Photosensitizer’s for Photodynamic Therapy | Best Researcher Award

Assoc. Prof at Moldova State University, Moldova

Tamara Potlog is an Associate Professor of Chemistry at Moldova State University. She has extensive experience in materials science, particularly in the field of organic/inorganic materials for optoelectronics and photovoltaics.

Profile

Orcid

scholar

🎓 Education

Tamara Potlog earned her Ph.D. on August 7, 1992. Her research expertise lies in the field of semiconductor physics and materials science.

👨‍🔬 Experience

Tamara Potlog has over 30 years of experience in academia and research. She is currently the Head of the Laboratory of Organic/Inorganic Materials for Optoelectronics and has supervised numerous master’s and Ph.D. theses. She has also managed several national and international projects, including the COST CA20116 and COST CA21148 projects.

🔍 Research Interest

Tamara Potlog’s research focuses on the design and fabrication of photosensitizers for photodynamic therapy and photovoltaics. Her team has developed novel materials and techniques for cancer treatment and solar energy applications.

Awards and Honors 🏆

Tamara Potlog has received numerous awards and honors for her research contributions, including 20 medals (gold, silver, and bronze) at international exhibitions of inventions and innovations.

📚 Publications 

1. Effect of deposition temperature on structural, morphological and optical properties of ZnTe thin films. 📊
2. DC current-voltage and impedance spectroscopy characterization of nCdS/pZnTe HJ. 💡
3. Thermally Annealed in Vacuum Undoped and Al-Doped ZnO Thin Films for Multifunctional Applications. 🔥
4. Physical-Chemical Properties of Self-Assembled Structures in Solution of Zinc Phthalocyanine and Bis-3-pentyl-PTCDI Derivative. 🌟
5. Influence of RF sputtering power and thickness on structural and optical properties of NiO thin films. 💻
6. The Photophysical Properties of Ga-doped ZnO Thin Films Grown by Spray Pyrolysis Method. ☀️
7. Photophysical properties of linked zinc phthalocyanine to acryloyl chloride:N-vinylpyrrolidone copolymer. 🎯
8. Photophysics of tetracarboxy-zinc phthalocyanine photosensitizers. 🔬
9. Reduced Recombination Current Due to Sputtered CdO Nanolayer at CdS/CdTe Interface. 💡
10. Photosensitizers for photodynamic and photovoltaic therapy. 🌞

Conclusion

Dr. Tamara Potlog is a strong candidate for the Research for Best Researcher Award, given her extensive research experience, leadership roles, and project management expertise. Her research focus on photosensitizers for photodynamic therapy and photovoltaics demonstrates innovation and potential for practical applications. With some further emphasis on international collaboration, citation impact, and research commercialization, she could further enhance her research profile and impact. Overall, she is a deserving candidate for the Research for Best Researcher Award.

Dr. Claudia Bardoni | Chemo-Immunotherapy | Best Research Award

Posted on by ScienceFather

Dr. Claudia Bardoni | Chemo-Immunotherapy | Best Research Award

MD FACS, IEO, Italy

Claudia Bardoni is a thoracic surgeon with extensive experience in thoracic surgery and research. Currently, she works as an Associate Thoracic Surgeon at the European Institute of Oncology (IEO) and is a member of the Nova Talent Network. She has worked in various prestigious institutions, including Università degli Studi di Milano and Cleveland Clinic Abu Dhabi.

Profile

orcid

🎓 Education

Although specific educational details are not provided, her experience suggests a strong foundation in medicine and surgery. She has completed fellowships in thoracic surgery, robotics, and microsurgery.

👨‍🔬 Experience

– Thoracic Surgeon at IEO- Resident Doctor at Università degli Studi di Milano- Clinical Fellow at Cleveland Clinic Abu Dhabi- Surgical Fellow at Klinikum Ernst von Bergmann- Medical Doctor in Covid-19 department

🔍 Research Interest

– Thoracic surgery- Lung transplant- Regenerative medicine- Robotics and microsurgery

🏆Awards and Honors

No specific awards or honors are mentioned, but her membership in the Nova Talent Network, which gathers the top 3% of professionals worldwide, is notable.

📚 Publications

– Evaluation of Methodological Quality of Published Guidelines: Dr. Bardoni co-authored a study evaluating the methodological quality of published guidelines for the surgical treatment of pleural mesothelioma, published in the European Journal of Cancer Prevention in 2023.
– Surgical Management of Superior Sulcus Tumors: She was part of a team that published a 20-year experience of surgical management of superior sulcus tumors at an oncological high-volume referral center in Frontiers in Oncology in 2023.
– Surgical Resection of Pulmonary Metastases: Dr. Bardoni contributed to a multicentric study on surgical resection of pulmonary metastases from melanoma in oligometastatic patients, published in Cancers in 2023.
– Non-Small Cell Lung Cancer: She co-authored a 20-year single-center retrospective study on surgically treated pT2aN0M0 non-small cell lung cancer, published in the Journal of Clinical Medicine in 2023.
– Molecular Biomarkers in Lung Cancer: Dr. Bardoni was involved in a narrative review analyzing molecular biomarkers in resected early-stage non-small cell lung cancer, published in Cancers in 2022.

Some of her other research interests and publications focus on:
– Reducing Postoperative Costs: Dr. Bardoni explored ways to reduce postoperative costs in thoracic surgery, including the use of oral management procedures to prevent complications.
– Body Composition and Complications: She investigated the relationship between CT-derived body composition values and complications after pneumonectomy in lung cancer patients ⁴.

Conclusion

This individual has a strong profile, with prestigious affiliations and editorial roles. While they have a solid foundation in research and clinical practice, more emphasis on publishing research findings, securing funding, and international collaborations would strengthen their application for the Best Researcher Award. With some additional focus on showcasing research achievements, they could demonstrate their suitability for the award.

Denian Wang | Tumor microenvironment | Young Scientist Award

Posted on by ScienceFather

Assoc Prof Dr Denian Wang | Tumor microenvironment | Young Scientist Award

Assoc Prof Dr Denian Wang , West China Hospital of Sichuan University , China

Denian Wang is an Associate Professor at the Precision Medicine Center, West China Hospital, Sichuan University. His research focuses on tumor biology and cancer diagnostics, with a significant emphasis on the tumor microenvironment and early detection of lung cancer. Wang has garnered extensive funding for his work, including from the National Natural Science Foundation of China and the Natural Science Foundation of Sichuan Province. His research has resulted in numerous high-impact publications, reflecting his expertise and contribution to the field. Wang is dedicated to advancing cancer research and improving clinical outcomes through innovative approaches. 🔬📚

Publication Profile

Scopus

Strengths for the Award

  1. Innovative Research Focus: Dr. Denian Wang’s research on tumor microenvironment, tumor metabolism, and early diagnosis of lung cancer aligns with cutting-edge areas of cancer research. His work on the immune microenvironment and tumor metabolism is particularly noteworthy for advancing understanding in these critical areas.
  2. High-Impact Publications: Dr. Wang has published extensively in high-impact journals such as Nature Communications and Breast Cancer Research. His research is well-regarded in the field, as evidenced by the impact factors of the journals and the citations of his work.
  3. Significant Funding: Dr. Wang has secured substantial funding from prominent sources, including the National Natural Science Foundation of China and the Natural Science Foundation of Sichuan Province. This reflects strong support for his research and its perceived importance in the scientific community.
  4. Diverse Research Contributions: His diverse publications cover a range of topics within cancer biology and related fields, indicating a broad expertise and a significant contribution to various aspects of the field.

Areas for Improvement

  1. Broader Impact and Outreach: While Dr. Wang’s research is highly specialized, increasing efforts to translate findings into clinical practice or public health improvements could enhance the broader impact of his work.
  2. Collaborative Networks: Expanding collaborations with international researchers and institutions could further enhance the visibility and impact of his research. This could also facilitate access to additional resources and expertise.
  3. Integration of Emerging Technologies: Incorporating emerging technologies, such as advanced bioinformatics or AI-driven approaches, could potentially enhance the scope and impact of his research.

Education

Denian Wang completed his Postdoctoral training in Clinical Medicine at West China Hospital, Sichuan University (2019-2022). He earned his PhD in Cell Biology from the State Key Laboratory of Biotherapy, Sichuan University (2014-2019). His education has provided a robust foundation in clinical and research medicine, equipping him with the skills necessary for cutting-edge research in cancer biology. 🎓🧬

Experience

Denian Wang is currently an Associate Professor at the Precision Medicine Center, West China Hospital, Sichuan University (2022-present). Prior to this, he served as an Associate Professor and Assistant Professor in the Department of Respiratory and Critical Care Medicine at the same hospital (2019-2022). His roles involved advanced research, clinical practice, and mentoring within the fields of respiratory medicine and clinical research. 🏥👨‍⚕️

Research Focus

Denian Wang’s research interests include the tumor microenvironment, tumor metabolism, and immune interactions within cancer. He is particularly focused on early lung cancer diagnosis and using deep learning for malignancy risk estimation. His work aims to enhance understanding of cancer biology and improve diagnostic and therapeutic strategies. 🧪🔍

Publications Top Notes

  1. Intermedin protects against sepsis by concurrently re-establishing the endothelial barrier and alleviating inflammatory responses – Nat Commun, 2018. 🌟
  2. Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence – Breast Cancer Res, 2020. 🌟
  3. Blockade of macrophage-associated programmed death 1 inhibits the pyroptosis signalling pathway in sepsis – Inflamm Res, 2021. 🌟
  4. Tau aggravates stress-induced anxiety by inhibiting adult ventral hippocampal neurogenesis in mice – Cereb Cortex, 2023. 🌟
  5. Endoplasmic Reticulum Peroxynitrite Fluctuations in Hypoxia-Induced Endothelial Injury and Sepsis with a Two-Photon Fluorescence Probe – Anal Chem, 2023. 🌟
  6. LACTB suppresses migration and invasion of glioblastoma via downregulating RHOC/Cofilin signaling pathway – Biochem Biophys Res Commun, 2022. 🌟
  7. Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysis – Medicine (Baltimore), 2018. 🌟
  8. Simultaneous Monitoring of HOCl and Viscosity with Drug-Induced Pyroptosis in Live Cells and Acute Lung Injury – Anal Chem, 2022. 🌟
  9. Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation – Breast Cancer Res Treat, 2022. 🌟
  10. 4R Tau Modulates Cocaine-Associated Memory through Adult Dorsal Hippocampal Neurogenesis – J Neurosci, 2021. 🌟

Conclusion:

Dr. Denian Wang is a strong candidate for the Research for Young Scientist Award due to his innovative research, high-impact publications, and significant funding achievements. His work contributes significantly to the understanding of cancer biology and offers potential advancements in early diagnosis and treatment. Addressing areas for improvement, such as broader impact and enhanced collaboration, could further strengthen his position as a leading researcher in his field. Overall, his accomplishments and ongoing contributions make him a deserving candidate for this prestigious award.

 

 

 

Harry Fuentes | Head and Neck Oncology | Best Researcher Award

Posted on by ScienceFather
Dr. Mayo Clinic, United States

This detailed academic and professional record belongs to Dr. Harry Eduardo Fuentes Bayne, MD, MS. He is an Assistant Professor of Oncology and Assistant Professor of Medicine at the Mayo Clinic College of Medicine and Science, with current positions as a Consultant in the Division of Medical Oncology, Department of Oncology at Mayo Clinic, Rochester, Minnesota.

 

Professional Profiles:

google Scholar

Education:

Doctor of Medicine Universidad de Guayaquil, Guayaquil, Ecuador 05/02/2005 – 09/13/2011Residency, Internal Medicine John H. Stroger Jr, Hospital of Cook County, Chicago, Illinois 07/01/2014 – 06/30/2017Masters of Clinical Research Rush University, Chicago, Illinois 05/13/2015 – 05/13/2017Chief Resident John H. Stroger Jr, Hospital of Cook County, Chicago, Illinois 07/01/2017 – 06/30/2018Fellow, Hematology/Oncology Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, Rochester, Minnesota 07/01/2018 – 06/30/2021Chief Fellow Mayo Clinic Division of Hematology/Oncology Fellowship, Rochester, Minnesota 06/01/2020 – 06/01/2021

Honors and Awards:

Mencion de HonorEscuela de Medicina de la Universidad de Guayaquil Annual Academic Achievement award received each year of Medical School (7 years)
06/01/2005 – 09/01/2011Premio Contenta Escuela de Medicina de la Universidad de Guayaquil Highest academic performance recognition given to a Medical Graduate.
09/01/2011 – PresentPremio Unico Ministry of Public Health of Ecuador Awarded by the National Institute of Hygiene and Tropical Medicine 11/15/2011 – Present

Strengths for the Award

  1. Educational Background and Training: Dr. Fuentes-Bayne has a robust educational and training background, including:
    • A Doctor of Medicine from Universidad de Guayaquil.
    • Residency in Internal Medicine at John H. Stroger Jr. Hospital of Cook County.
    • A Master’s in Clinical Research from Rush University.
    • Fellowship and Chief Fellowship in Hematology/Oncology at Mayo Clinic.
  2. Honors and Awards: He has received multiple prestigious awards, including:
    • Mencion de Honor from Escuela de Medicina de la Universidad de Guayaquil.
    • Premio Contenta, recognizing highest academic performance.
    • Premio Unico from the Ministry of Public Health of Ecuador.
  3. Leadership and Expertise: His role as Chief Resident and Chief Fellow indicates strong leadership skills and advanced expertise in his field. His extensive training in Hematology/Oncology is particularly noteworthy.
  4. Institutional Affiliation: Being affiliated with Mayo Clinic, a leading institution, adds credibility and indicates a high level of expertise and access to cutting-edge research and clinical resources.

Areas for Improvement

  1. Publication Record: While the provided highlights his educational and award history, details on his publication record, research contributions, or specific projects in hematology/oncology would be beneficial. A strong publication record in high-impact journals is often a key criterion for research awards.
  2. Research Impact: Information on the impact of his research, such as citation counts, novel contributions to the field, or involvement in significant research projects, would provide a clearer picture of his influence in the field.
  3. Continued Professional Development: Details on ongoing research activities, involvement in conferences, or contributions to professional societies would enhance the understanding of his current research engagement and professional growth.

 

✍️Publications Top Note :

Comparative effectiveness of anticoagulants in patients with cancer-associated thrombosis

Authors: IB Riaz, H Fuentes, Y Deng, SAA Naqvi, X Yao, LR Sangaralingham, …

Journal: JAMA Network Open

Volume/Issue: 6 (7), e2325283-e2325283

Citations: 11

Year: 2023

Risk assessment as a guide for the prevention of cancer-associated thromboembolism

Authors: A Al-Ogaili, HE Fuentes, AJ Tafur, J Caprini

Journal: International Angiology

Volume/Issue: Not specified

Citations: 9

Year: 2018

Primary liver diffuse large B-cell lymphoma following complete response for hepatitis C infection after direct antiviral therapy

Authors: XA Andrade, LH Paz, DM Oramas, HE Fuentes, P Kovarik, S Mishra, …

Journal: Acta Haematologica

Volume/Issue: 139 (2), 77-80

Citations: 9

Year: 2018

Predictors of active cancer thromboembolic outcomes: mortality associated with calf deep vein thrombosis

Authors: JPS Adum, LD Quintero, HE Fuentes, BB Lind, JA Caprini, AJ Tafur

Journal: International Angiology

Volume/Issue: Not specified

Citations: 9

Year: 2017

Conclusion

Dr. Harry Fuentes-Bayne demonstrates significant strengths in his educational background, leadership roles, and receipt of prestigious awards, which collectively position him as a strong candidate for a Research Award. To strengthen his candidacy further, providing detailed information about his research contributions, publication record, and ongoing projects would be advantageous. His strong academic and clinical background, coupled with notable awards, makes him a compelling candidate for recognition in the research community.